Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure

American Journal of Kidney Diseases

Volumn 35, Issue 2, 2000, Pages 250-256

  Hayashi, Terumasa ^a,b   Suzuki, Akira ^a,b   Shoji, Tatsuya ^a,b   Togawa, Masaki ^a,b   Okada, Noriyuki ^a,b   Tsubakihara, Yoshiharu ^a,b   Imai, Enyu ^a,b   Hori, Masatsugu ^a,b  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Chronic renal failure; Circadian blood pressure variation; Erythropoietin; Left ventricular hypertrophy; Target hematocrit

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMATOCRIT; HUMAN; MALE;

EID: 0033974161     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(00)70334-9     Document Type: Article

References (20)

1. RN Foley PS Parfrey JD Harnett GM Kent DC Murray PE Barre The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease Am J Kidney Dis 28 1996 53 61
2. F Moreno F Valderrabano FJ Aracil R Perez Influence of haematocrit on quality of life of haemodialysis patients Nephrol Dial Transplant 9 1994 1034A (abstr)
3. JW Eschbach R Glenny T Robertson M Guthrie B Rader R Evans W Chandler R Davidson T Easterling J Denney G Schneider Normalizing the hematocrit in hemodialysis patients with EPO improves quality of life and is safe J Am Soc Nephrol 4 1993 425A (abstr)
4. D Levy RJ Garrison DD Savage WB Kannel WP Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566
5. JS Silberberg PE Barre SS Prichard AD Sniderman Impact of left ventricular hypertrophy on survival in end-stage renal disease Kidney Int 36 1989 286 290
6. RN Foley PS Parfrey JD Harnett GM Kent CJ Martin DC Murray PE Barre Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 47 1995 186 192
7. J Pascual JL Teruel JL Moya F Liano M Jimenez-Mena J Ortuno Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: A prospective study Clin Nephrol 35 1991 280 287
8. C Zehnder M Zuber M Sulzer B Meyer E Straumann HR Jenzer A Blumberg Influence of long-term amelioration of anemia and blood pressure control on left ventricular hypertrophy in hemodialyzed patients Nephron 61 1992 21 25
9. V Wizeman R Schafer W Kramer Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy Nephron 64 1993 202 206
10. DJ Sahn A DeMaria J Kisslo A Weyman Recommendations regarding quantitation in M-mode echocardiography: Result of a survey of echocardiographic measurements Circulation 58 1978 1072 1083
11. LE Teichholz T Kreulen MV Herman A Weyman Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy Am J Cardiol 37 1976 7 11
12. RB Devereux N Reicheck Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method Circulation 55 1977 613 618
13. J Portolés A Torralbo P Martin J Rodrigo JA Herrero A Barrientos Cardiovascular effects of recombinant human erythropoietin in predialysis patients Am J Kidney Dis 29 1997 541 548
14. WE Mitch M Walser GA Buffington J Lemann Jr A simple method of estimating progression of chronic renal failure Lancet 2 1976 1326 1328
15. F Valderrabano EHP Jones NP Mallick Report on management of renal failure in Europe, XXIV, 1993 Nephrol Dial Transplant 10 suppl 5 1995 S1 S25
16. JFE Mann Hypertension and cardiovascular effects: Long-term safety and potential long-term benefits of r-HuEPO Nephrol Dial Transplant 10 suppl 2 1995 S80 S84
17. NKF Anemia Work Group NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure Am J Kidney Dis 30 suppl 3 1997 S192 S237
18. DL Garcia S Anderson HG Rennke BM Brenner Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass Proc Natl Acad Sci USA 85 1988 6142 6146
19. MG Myers Trough to peak ratio and 24-hour blood pressure control Am J Hypertens 8 1995 214 219
20. J Bergstrom A Alvestrand H Bucht A Gutierrez Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control Clin Nephrol 25 1986 1 6